Distinct β-Cell Defects in Impaired Fasting Glucose and Impaired Glucose Tolerance
Open accessThe DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Abstract
To characterize the defects in β-cell function in subjects with impaired fasting glucose (IFG) and compare the results to impaired glucose tolerance (IGT) and normal glucose tolerance (NGT) subjects, β-cell glucose sensitivity and rate sensitivity during the oral glucose tolerance test were measured with the model by Mari in 172 Mexican Americans. A subgroup (n = 70) received a 2-h hyperglycemic clamp (+125 mg/dL), and first- and second-phase insulin secretion were quantitated. Compared with NGT, subjects with IFG and IGT manifested a decrease in β-cell glucose sensitivity; IFG subjects, but not IGT subjects, had decreased β-cell rate sensitivity. In IFG subjects, the defect in β-cell glucose sensitivity was time dependent, began to improve after 60 min, and was comparable to NGT after 90 min. The incremental area under the plasma C-peptide concentration curve during the first 12 min of the hyperglycemic clamp (ΔC-pep[AUC]0–12) was inversely related with the increase in FPG concentration (r = −36, r = 0.001), whereas ΔC-pep[AUC]15–120 positively correlated with FPG concentration (r = 0.29, r < 0.05). When adjusted for the prevailing level of insulin resistance, first-phase insulin secretion was markedly decreased in both IFG and IGT, whereas second-phase insulin secretion was decreased only in IGT. These results demonstrate distinct defects in β-cell function in IFG and IGT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“These results demonstrate a definite beta-cell defect in IFG and IGT.[21]”
From Postprandial Reactive Hypoglycemia (2019) · cites this paper as [21]
In the citing paper
“β-cell dysfunction is present both in people with isolated IFG and isolated IGT. IFG people have severely impaired early insulin response during OGTT but their insulin secretion improves during the second phase of the OGTT. In contrast, IGT people present with impaired early and late phase insulin secretion.38,39,50”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [50]
In the citing paper
“These findings suggest distinct pathophysiological mechanisms of isolated IFG and isolated IGT although the clinical relevance of these observations requires further clarification.”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [50]
In the citing paper
“IFG is characterized primarily by impaired hepatic insulin sensitivity and a decrease in the first-phase insulin response”
From The Vasculature in Prediabetes (2018) · cites this paper as [13]
In the citing paper
“IGT is characterized by impaired muscle insulin sensitivity as well as early and late phase insulin responses.”
From The Vasculature in Prediabetes (2018) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425 · cited 2×
“The glucose infusion rate divided by the mean plasma insulin concentration during the hyperglycemic clamp (0–120), an index of insulin sensitivity (26), was markedly reduced by 54% in subjects with IGT (P , 0.”
BackgroundMethodSelf-citationReport of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
Writing committee, Unwin, N., Shaw, J., Zimmet, P., & Alberti, K. G. M. M. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00835.x · Cited by 1,108
Abdul-Ghani, M. A., Tripathy, D., & DeFronzo, R. A. (2006) · Diabetes Care · doi:10.2337/dc05-2179 · Cited by 744
Self-citationGerstein, H. C., Santaguida, P., Raina, P., Morrison, K. M., Balion, C., Hunt, D., Yazdi, H., & Booker, L. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.05.004 · Cited by 575
Ferrannini, E., Gastaldelli, A., Miyazaki, Y., Matsuda, M., Mari, A., & DeFronzo, R. A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1133 · Cited by 540 · cited 5×
“b-Cell glucose sensitivity, rate sensitivity, and the potentiation factor were calculated with the model by Mari (12,22).”
MethodSelf-citationAbdul-Ghani, M. A., Jenkinson, C. P., Richardson, D. K., Tripathy, D., & DeFronzo, R. A. (2006) · Diabetes · doi:10.2337/db05-1200 · Cited by 500 · cited 2×
“This can be explained by 1) the time-related improvement in b-cell glucose sensitivity during the 60–120 min time period; 2) the increase in potentiation factor (Table 2); and 3) normal to near-normal muscle insulin sensitivity (9).”
BackgroundSelf-citationThe Effect of Insulin Treatment on Insulin Secretion and Insulin Action in Type II Diabetes Mellitus
Garvey, W. T., Olefsky, J. M., Griffin, J., Hamman, R. F., & Kolterman, O. G. (1985) · Diabetes · doi:10.2337/diab.34.3.222 · Cited by 488 · cited 1×
“Conversely, improving glycemic control in type 2 diabetic subjects with insulin therapy improves b-cell function (27), and experimental studies in animals (28–30) have reported that a small rise (16 mg/dL) in FPG concentration is associated with a marked inhibition of glucose-stimulated insulin secretion, whereas corr…”
BackgroundEffect of chronic hyperglycemia on in vivo insulin secretion in partially pancreatectomized rats.
Rossetti, L., Shulman, G. I., Zawalich, W., & DeFronzo, R. A. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113157 · Cited by 330 · cited 1×
“Conversely, improving glycemic control in type 2 diabetic subjects with insulin therapy improves b-cell function (27), and experimental studies in animals (28–30) have reported that a small rise (16 mg/dL) in FPG concentration is associated with a marked inhibition of glucose-stimulated insulin secretion, whereas corr…”
BackgroundSelf-citation
Cited by
Prediabetes: a high-risk state for diabetes development
Tabák, A. G., Herder, C., Rathmann, W., Brunner, E. J., & Kivimäki, M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60283-9 · Cited by 2,958
Diabetes mellitus statistics on prevalence and mortality: facts and fallacies
Zimmet, P., Alberti, K. G., Magliano, D. J., & Bennett, P. H. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.105 · Cited by 785
Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents
Di Pino, A., & DeFronzo, R. A. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00141 · Cited by 535
Self-citationMetabolic Effects of Bariatric Surgery in Patients With Moderate Obesity and Type 2 Diabetes
Kashyap, S. R., Bhatt, D. L., Wolski, K., Watanabe, R. M., Abdul-Ghani, M., Abood, B., Pothier, C. E., Brethauer, S., Nissen, S., Gupta, M., et al. (2013) · Diabetes Care · doi:10.2337/dc12-1596 · Cited by 286
Self-citationKe, C., Narayan, K. M. V., Chan, J. C. N., Jha, P., & Shah, B. R. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00669-4 · Cited by 239
The Spectrum of Achalasia: Lessons From Studies of Pathophysiology and High-Resolution Manometry
Kahrilas, P. J., & Boeckxstaens, G. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.08.038 · Cited by 235
Update on cystic fibrosis-related diabetes
Kelly, A., & Moran, A. (2013) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2013.02.008 · Cited by 203
“6 mmol/ L) during the OGTT is associated with increased likelihood of progression and evidence of carotid atherosclerosis compared to individuals with NGT and one hour plasma glucose less than this threshold [70,109,110] — suggesting even those lower glucose concentrations may be relevant.”
BackgroundBrannick, B., Wynn, A., & Dagogo-Jack, S. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216654227 · Cited by 177
Effects of Bariatric Surgery on Glucose Homeostasis and Type 2 Diabetes
Bradley, D., Magkos, F., & Klein, S. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.07.114 · Cited by 152
Li, X., Sun, M., Yang, Y., Yao, N., Yan, S., Wang, L., Hu, W., Guo, R., Wang, Y., & Li, B. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.862919 · Cited by 160
“IFG refers to liver IR and early insulin secretion defects, along with impaired b-cell function (41, 42).”
BackgroundHeiskanen, M. A., Motiani, K. K., Mari, A., Saunavaara, V., Eskelinen, J.-J., Virtanen, K. A., Koivumäki, M., Löyttyniemi, E., Nuutila, P., Kalliokoski, K. K., et al. (2018) · Diabetologia · doi:10.1007/s00125-018-4627-x · Cited by 142
“Beta cell functional variables have been shown to have distinct patterns of decrease when spanning the range from normoglycaemic obese individuals to those with overt type 2 diabetes [36], and even beta cell defects in impaired fasting glucose and impaired glucose tolerance are different [37].”
BackgroundSelf-citationThe Vasculature in Prediabetes
Wasserman, D. H., Wang, T. J., & Brown, N. J. (2018) · Circulation Research · doi:10.1161/circresaha.118.311912 · Cited by 137
Evidence of Reduced β-Cell Function in Asian Indians With Mild Dysglycemia
Staimez, L. R., Weber, M. B., Ranjani, H., Ali, M. K., Echouffo-Tcheugui, J. B., Phillips, L. S., Mohan, V., & Narayan, K. M. V. (2013) · Diabetes Care · doi:10.2337/dc12-2290 · Cited by 313
Jiménez-Lucena, R., Camargo, A., Alcala-Diaz, J. F., Romero-Baldonado, C., Luque, R. M., van Ommen, B., Delgado‐Lista, J., Ordovás, J. M., Pérez‐Martínez, P., Rangel-Zúñiga, O. A., et al. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0194-y · Cited by 147
Benefit of lifestyle-based T2DM prevention is influenced by prediabetes phenotype
Campbell, M. D., Sathish, T., Zimmet, P., Thankappan, K. R., Oldenburg, B. F., Owens, D. R., Shaw, J. E., & Tapp, R. J. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0316-1 · Cited by 135
Michaliszyn, S. F., Mari, A., Lee, S., Bacha, F., Tfayli, H., Farchoukh, L., Ferrannini, E., & Arslanian, S. (2014) · Diabetes · doi:10.2337/db13-1951 · Cited by 92
Self-citationClassification and Diagnosis of Diabetes
GENUTH, S. M., Palmer, J. P., & Nathan, D. M. (2018) · Cited by 112
Hsueh, W., McLellan, K., Wyne, K., & Villagomez, E. (2014) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s39564 · Cited by 91
Kanat, M., DeFronzo, R. A., & Abdul-Ghani, M. A. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i12.1207 · Cited by 82
Self-citationLian, F., Li, G., Chen, X., Wang, X., Piao, C., Wang, J., Hong, Y., Ba, Z., Wu, S., Zhou, X., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3276 · Cited by 82
Mørkrid, K., Jenum, A. K., Sletner, L., Vårdal, M. H., Waage, C. W., Nakstad, B., Vangen, S., & Birkeland, K. I. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0452 · Cited by 83
Unnikrishnan, R., Shaw, J. E., Chan, J. C. N., Wild, S. H., Peters, A. L., Orrange, S., Roden, M., & Mohan, V. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-025-00635-0 · Cited by 77
“On the other hand, isolated IGT is increasingly associated with insulin resistance in skeletal muscles along with reduced β-cell function 6,62 .”
Mathematical models of electrical activity of the pancreatic β-cell: A physiological review
Félix‐Martínez, G. J., & Godínez-Fernández, J. R. (2014) · Islets · doi:10.4161/19382014.2014.949195 · Cited by 72
Guess, N. D. (2018) · Nutrients · doi:10.3390/nu10091245 · Cited by 75
Wagner, H., Alvarsson, M., Mannheimer, B., Degerblad, M., & Östenson, C. (2016) · Diabetes Care · doi:10.2337/dc15-1057 · Cited by 65
Health risks and interventions in prediabetes: A review
Mahat, R. K., Singh, N., Arora, M., & Rathore, V. (2019) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2019.07.041 · Cited by 52
Jiménez‐Maldonado, A., García‐Suárez, P. C., Rentería, I., Moncada‐Jiménez, J., & Plaisance, E. P. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165820 · Cited by 64
“Elevated responses during OGTT typically indicate IR in skeletal muscle more than other tissues such as liver [142].”
BackgroundInhibitory G proteins and their receptors: emerging therapeutic targets for obesity and diabetes
Kimple, M. E., Neuman, J. C., Linnemann, A. K., & Casey, P. J. (2014) · Experimental & Molecular Medicine · doi:10.1038/emm.2014.40 · Cited by 55
Merovci, A., Abdul‐Ghani, M. A., Mari, A., Solis‐Herrera, C., Xiong, J., Daniele, G., Tripathy, D., & DeFronzo, R. A. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2597 · Cited by 48
Self-citationGabriel, R., Boukichou-Abdelkader, N., Acosta, T., Gilis‐Januszewska, A., Gómez‐Huelgas, R., Makrilakis, K., Kamenov, Z. A., Paulweber, B., Satman, İ., Djordjević, P., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0231196 · Cited by 52
Henquin, J. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101212 · Cited by 54
Postprandial Reactive Hypoglycemia
Altuntaş, Y. (2019) · SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital · doi:10.14744/semb.2019.59455 · Cited by 69
“Thus, before type 2 diabetes, IFG also took place after IGT.”
ResultInfluentialAbdul‐Ghani, M. A., DeFronzo, R. A., & Jayyousi, A. (2016) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000307 · Cited by 57
Self-citationZhou, Q., Ge, Q., Ding, Y., Qu, H., Wei, H., Wu, R., Lu, Y., Wei, Q., Feng, Z., Long, J., et al. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12819 · Cited by 43
Paing, A. C., McMillan, K. A., Kirk, A. F., Collier, A., Hewitt, A., & CHASTIN, S. F. M. (2018) · Diabetic Medicine · doi:10.1111/dme.13829 · Cited by 40
Chronic Microvascular Complications in Prediabetic States—An Overview
Baranowska-Jurkun, A., Matuszewski, W., & Bandurska-Stankiewicz, E. M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9103289 · Cited by 43
“Early (0–30 min) insulin response during OGTT and insulin secretion in the first phase (0–10 min) during the hyperglycemic clamp and intravenous glucose tolerance test are disturbed in IFG [32].”
BackgroundMalin, S. K., Kullman, E. L., Scelsi, A. R., Godin, J., Ross, A. B., & Kirwan, J. P. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201800967 · Cited by 42
Prevalence and predictors of non-alcoholic fatty liver disease in prediabetes
Rajput, R., & Ahlawat, P. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.07.060 · Cited by 36
Malin, S. K., Liu, Z., Barrett, E. J., & WELTMAN, A. L. (2016) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-016-9352-5 · Cited by 39
Perito, E. R., Lustig, R. H., & Rosenthal, P. J. (2016) · American Journal of Transplantation · doi:10.1111/ajt.13714 · Cited by 34
Elevation of one hour plasma glucose during oral glucose tolerance testing
Sheikh, S., Putt, M., Forde, K. A., Rubenstein, R. C., & Kelly, A. T. (2015) · Pediatric Pulmonology · doi:10.1002/ppul.23237 · Cited by 33
Robertson, T. M., Clifford, M. N., Penson, S., Williams, P., & Robertson, M. D. (2018) · British Journal Of Nutrition · doi:10.1017/s0007114518000260 · Cited by 32
Abdul-Ghani, M. A., Jobori, H. A., Daniele, G., Adams, J. M., Cersósimo, E., Triplitt, C. L., & DeFronzo, R. A. (2017) · Diabetes · doi:10.2337/db17-0055 · Cited by 33
Self-citationThe impact of ethnicity on glucose homeostasis after gestational diabetes mellitus
Ignell, C., Shaat, N., Ekelund, M., & Berntorp, K. (2013) · Acta Diabetologica · doi:10.1007/s00592-013-0484-8 · Cited by 30
Prediabetes increases the risk of major limb and cardiovascular events
Hsu, J., Yang, Y., Chuang, S.-L., Lee, J., & Lin, L. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-02085-y · Cited by 29
Sox17 Regulates Insulin Secretion in the Normal and Pathologic Mouse β Cell
Jonatan, D., Spence, J. R., Method, A. M., Kofron, M. J., Sinagoga, K. L., Haataja, L., Arvan, P., Deutsch, G. H., & Wells, J. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104675 · Cited by 34
Malin, S. K., François, M. E., Eichner, N. Z. M., Gilbertson, N. M., Heiston, E. M., Fabris, C., & Breton, M. D. (2018) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00680.2018 · Cited by 27
Çolak, A., Akıncı, B., Dınız, G., Türkön, H., Ergonen, F., Yalçın, H., & Çoker, I. (2013) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2013.798870 · Cited by 28
Effects of Leptin Replacement Therapy on Pancreatic β-Cell Function in Patients With Lipodystrophy
Muniyappa, R., Brown, R. J., Mari, A., Joseph, J., Warren, M. A., Cochran, E. K., Skarulis, M. C., & Gorden, P. (2014) · Diabetes Care · doi:10.2337/dc13-2040 · Cited by 24
Self-citationAoyama‐Sasabe, S., Fukushima, M., Xin, X., Taniguchi, A., Nakai, Y., Mitsui, R., Takahashi, Y., Tsuji, H., Yabe, D., Yasuda, K., et al. (2015) · Journal of Diabetes Research · doi:10.1155/2016/1298601 · Cited by 26
Palmatine ameliorates high fat diet induced impaired glucose tolerance
Tian, X., Zhang, Y., Li, H., Li, Y., Wang, N., Zhang, W., & Boyan, M. (2020) · Biological Research · doi:10.1186/s40659-020-00308-0 · Cited by 23
Wang, D., Jiang, D.-M., Yu, R.-R., Zhang, L., Liu, Y.-Z., Chen, J.-X., Chen, H., & Liu, Y. (2022) · Journal of Diabetes Research · doi:10.1155/2022/3780156 · Cited by 24
“IGT shows insulin resistant (IR) and will develop into type 2 diabetes mellitus (T2DM) [3].”
BackgroundPrayGod, G., Changalucha, J. M., Kapiga, S., Peck, R. N., Todd, J., & Filteau, S. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2209-z · Cited by 23
Mengozzi, A., Tricò, D., Nesti, L., Petrie, J. R., Højlund, K., Mitrakou, A., Krebs, M., Mari, A., & Natali, A. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154185 · Cited by 22
Self-citationYu, L. J., Feng, D., Esangbedo, I. C., Zhao, Y., Han, L., Zhu, Y., Fu, J., Li, G., Wang, D., Wang, Y., et al. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000724 · Cited by 21
Ramírez, G. R., Simental‐Mendía, L. E., Carrera-Gracia, M., & Escorza, M. A. Q. (2017) · Archives of Medical Research · doi:10.1016/j.arcmed.2017.03.018 · Cited by 24
Jagannathan, R., Snehalatha, C., Selvam, S., Nanditha, A., Shetty, A. S., Godsland, I. F., Johnston, D. G., & Ramachandran, A. (2015) · Acta Diabetologica · doi:10.1007/s00592-015-0718-z · Cited by 20
Giuseppe, G. D., Ciccarelli, G., CEFALO, C. M. A., Cinti, F., Moffa, S., Impronta, F., Capece, U., Pontecorvi, A., Giaccari, A., & Mezza, T. (2021) · Minerva Endocrinology · doi:10.23736/s2724-6507.21.03405-9 · Cited by 17
Scholz, G. H., & Fleischmann, H. (2014) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018814556099 · Cited by 18
Prediabetes: Evaluation of β-Cell Function
Basu, A., Pedersen, M. G., & Cobelli, C. (2012) · Diabetes · doi:10.2337/db11-1677 · Cited by 15
Ebenibo, S., Edeoga, C., Wan, J. Y., & Dagogo-Jack, S. E. (2014) · Metabolism · doi:10.1016/j.metabol.2014.03.002 · Cited by 15
Ali, A. M., Mari, A., MARTINEZ, R. A., Jobori, H. A., Adams, J. M., Triplitt, C. L., DeFronzo, R. A., Cersósimo, E., & Abdul‐Ghani, M. A. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa494 · Cited by 16
Self-citationJung, J. Y., Park, S. K., Oh, C., Ryoo, J., Choi, J., & Choi, Y. J. (2018) · Acta Diabetologica · doi:10.1007/s00592-018-1112-4 · Cited by 15
“Subjects with IFG have a severe impairment in first-phase insulin secretion in response to both oral (0–30 min) and intravenous (0–12 min) glucose stimuli, but have the nearly normal or increased second-phase insulin secretion during the hyperglycemic clamp [26, 27].”
Bahadoran, Z., Ghafouri-Taleghani, F., Azizi, F., & Ghasemi, A. (2025) · Biological Trace Element Research · doi:10.1007/s12011-025-04545-w · Cited by 15
“Isolated IFG is mainly marked by moderate-sever hepatic insulin resistance and impaired first-phase insulin secretion, as evidenced by elevated FSG and a sharp rise in glucose during the first 60 min of an OGTT, with levels normalizing after 2 h [4, 58].”
Serum osteopontin predicts glycaemic profile improvement in metabolic syndrome: A pilot study
Caserza, L., Casula, M., Elia, E., Bonaventura, A., Liberale, L., Bertolotto, M. B., Artom, N., Minetti, S., Contini, P., Verzola, D., et al. (2020) · European Journal of Clinical Investigation · doi:10.1111/eci.13403 · Cited by 14
Pathogenesis of Type 2 Diabetes Mellitus
DeFronzo, R. A. (2018) · Endocrinology · doi:10.1007/978-3-319-45015-5_8 · Cited by 16
Self-citationWinnier, D., Norton, L., Kanat, M., Arya, R. R., Fourcaudot, M. J., HANSIS-DIARTE, A. A., Tripathy, D., DeFronzo, R. A., Jenkinson, C. P., & Abdul-Ghani, M. A. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2886 · Cited by 13
Self-citationKohnert, K., Heinke, P., Vogt, L., Augstein, P., & Salzsieder, E. (2014) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2014.09.003 · Cited by 15
Liu, D., Qu, H., Wang, H., Duan, Y., Liu, F., Feng, Z., & Deng, H. (2016) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2016.08.004 · Cited by 13
Bahadoran, Z., Azizi, F., & Ghasemi, A. (2025) · Biological Trace Element Research · doi:10.1007/s12011-025-04609-x · Cited by 12
“Isolated IFG (iIFG) is characterized by moderate hepatic insulin resistance and impaired first-phase insulin secretion [2, 3].”
Lim, W. X. J., Gammon, C. S., von Hurst, P. R., Chepulis, L. M., & Page, R. (2021) · Nutrients · doi:10.3390/nu13113733 · Cited by 14
Elevated liver enzymes are related to progression to impaired glucose tolerance in Japanese men
Oka, R., Aizawa, T., Yagi, K., Hayashi, K., Kawashiri, M., & Yamagishi, M. (2013) · Diabetic Medicine · doi:10.1111/dme.12345 · Cited by 12
Romero‐García, T., Vázquez-Jiménez, J. G., Sánchez-Hernández, R., Olivares-Reyes, J. A., & Rueda, A. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1535153 · Cited by 12
Pathogenesis of Type 2 Diabetes Mellitus
DeFronzo, R. A. (2018) · Endocrinology · doi:10.1007/978-3-319-27317-4_8-1 · Cited by 13
Self-citationAbdul‐Ghani, T., PUCKETT, C. L., Migahid, O., Abdelgani, S., Migahed, A., Adams, J. M., Triplitt, C. L., DeFronzo, R. A., Jayyousi, A., & Abdul‐Ghani, M. A. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14767 · Cited by 10
Self-citationIncretin hormone receptors are required for normal beta cell development and function in female mice
Omar, B. A., Ahlkvist, L., Yamada, Y., Seino, Y., & Åhrén, B. (2016) · Peptides · doi:10.1016/j.peptides.2016.03.012 · Cited by 9
Primary Prevention of Type 2 Diabetes: An Imperative for Developing Countries
Dagogo-Jack, S. E. (2016) · Springer eBooks · doi:10.1007/978-3-319-41559-8_2 · Cited by 8
Celiac Disease and Pregnancy Outcomes in Patients with Gestational Diabetes Mellitus
Dalfrà, M. G., Vescovo, G. G. D., Burlina, S., Baldan, I., Pastrolin, S., & Lapolla, A. (2020) · International Journal of Endocrinology · doi:10.1155/2020/5295290 · Cited by 8
Effect of the Incretin Hormones on the Endocrine Pancreas in End-Stage Renal Disease
Jørgensen, M. B., Idorn, T., Rydahl, C., Hansen, H. P., Bressendorff, I. O., Brandi, L., Albrechtsen, N. J. W., van Hall, G., Hartmann, B., Holst, J. J., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz048 · Cited by 8
Insulin Secretion Predicts the Response to Antidiabetic Therapy in Patients With New-onset Diabetes
Abdelgani, S., PUCKETT, C. L., Adams, J. M., Triplitt, C. L., DeFronzo, R. A., & Abdul‐Ghani, M. A. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab403 · Cited by 8
Self-citationVaurs, C., Brun, J. ‐., Bérard, E., du Rieu, M. C., Hanaire, H. P., & Ritz, P. (2015) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2015.10.073 · Cited by 7
Bahadoran, Z., Mirmiran, P., Ghasemi, A., & Azizi, F. (2024) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-024-01517-0 · Cited by 7
“Because of the heterogeneous metabolic states occurring in the pathophysiology of iIFG and iIGT [6, 7], the risk of progression to T2D and its modifiers are heterogeneous across the Pre-DM spectrum [8–11].”
Abdelgani, S., PUCKETT, C. L., Adams, J. M., Triplitt, C. L., DeFronzo, R. A., & Abdul‐Ghani, M. A. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14383 · Cited by 6
Self-citationGabriel, R., Boukichou-Abdelkader, N., Gilis‐Januszewska, A., Makrilakis, K., Gómez‐Huelgas, R., Kamenov, Z. A., Paulweber, B., Satman, İ., Djordjević, P., Alkandari, A., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12052035 · Cited by 7
Li, Y., He, S.-H., Sun, Y., Li, G., Xu, Q., Wang, C., & Jia, W. (2017) · IUBMB Life · doi:10.1002/iub.1657 · Cited by 6
Si, Y., Shen, Y., Lu, J., Ma, X., Zhang, L., Mo, Y., Lu, W., Zhu, W., Bao, Y., Hu, G., et al. (2020) · Endocrine · doi:10.1007/s12020-020-02201-y · Cited by 6
Prediabetes: challenges and opportunities
Моргунова, Т. Б., Glinkina, I. V., & Fadeev, V. V. (2021) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2021-12-220-227 · Cited by 5
Zinc Alpha-2 Glycoprotein, Acylated Ghrelin, and Zinc Levels in Prediabetics
Kurtuluş, E. M., Karış, D., Ercan, M., & Konukoğlu, D. (2024) · In Vivo · doi:10.21873/invivo.13530 · Cited by 5
“Consequently, following a carbohydrate-rich meal or glucose intake, muscle insulin resistance hinders glucose uptake, resulting in postprandial hyperglycemia (21, 22).”
BackgroundLorenzo, C., Hanley, A. J., Rewers, M., & Haffner, S. M. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0565-3 · Cited by 5
“Defects in the biphasic release (early and late) of insulin in response to glucose can be demonstrated in the pre-diabetic state using the hyperglycemic clamp technique and the oral glucose tolerance test [1, 2].”
MethodVarlet‐Marie, E., Brun, J. ‐., Myzia, J., Bui, G., Chérif, A., Javernaud, E., Hammoudi, L., Mercier, J. G., & de Mauverger, É. R. (2022) · Science & Sports · doi:10.1016/j.scispo.2021.06.004 · Cited by 5
Nandhini, L. P., Kamalanathan, S., & Sahoo, J. (2019) · Springer eBooks · doi:10.1007/978-3-030-11815-0_6 · Cited by 10
Bahadoran, Z., Kashani, Z., Mahdavi, M., Mirmiran, P., & Azizi, F. (2025) · European journal of medical research · doi:10.1186/s40001-025-02337-5 · Cited by 4
Impaired Glucose Tolerance, Obesity and Inflammatory Mediators
Çolak, A., & Dınız, G. (2012) · InTech eBooks · doi:10.5772/52378 · Cited by 4
“In contrasts, subjects with IFG have impaired early –phase insulin secretion and increased IR in liver [6-8].”
BackgroundResultFu, Q., Sun, M., Wang, Z., He, W., Duan, Y., & Yang, T. (2017) · Endocrine Journal · doi:10.1507/endocrj.ej17-0325 · Cited by 4
Zimmet, P., & Alberti, K. G. M. M. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12793 · Cited by 4
Type 2 Diabetes: An Unresolved Disease
Cuschieri, S. (2020) · Springer eBooks · doi:10.1007/978-3-030-53370-0_41 · Cited by 5
Bahadoran, Z., Mirmiran, P., Azizi, F., & Hosseinpanah, F. (2024) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2024.08.024 · Cited by 3
Prediabetes in Transition: Insights from the Tehran Lipid and Glucose Study
Bahadoran, Z., & Hosseinpanah, F. (2025) · Intern J Endocrinol Metab · doi:10.5812/ijem-166455 · Cited by 4
Impaired glucose tolerance and mild diabetes induce β-cell dysfunction in mice
Haythorne, E., Lloyd, M., Smith, C. A., van de Bunt, M., Rohm, M., Elphick, A., Cyranka, M., Gribble, F. M., Reimann, F., & Ashcroft, F. M. (2026) · Nature Communications · doi:10.1038/s41467-026-71528-3 · Cited by 3
Commendatore, V., Faingold, C., Fenili, C., Frechtel, G. D., González, C. D., Llanos, I., Lucarelli, C., Maselli, M. D. C., Mazza, C., Puchulu, F., et al. (2023) · Revista de la Sociedad Argentina de Diabetes · doi:10.47196/diab.v57i1.676 · Cited by 8
Metadata
- Authors
- Kanat, M., Mari, A., Norton, L., Winnier, D., DeFronzo, R. A., Jenkinson, C., & Abdul-Ghani, M. A.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- Division of Diabetes, University of Texas Health Science Center at San Antonio, San Antonio, Texas
- Corresponding author
- Abdul-Ghani, Muhammad A.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2012-01-17
- Volume
- 61
- Issue
- 2
- Pages
- 447-453
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC3266412
- OpenAlex
- W2106830005
- Cited by
- 122
- References
- 35
- Citations by year
- 2026: 3 · 2025: 11 · 2024: 3 · 2023: 6 · 2022: 6 · 2021: 8 · 2020: 13 · 2019: 9 · 2018: 13 · 2017: 6 · 2016: 12 · 2015: 6 · 2014: 14 · 2013: 7 · 2012: 5
- FWCI
- 10.42
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK079195)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- beta-cell function, impaired fasting glucose, impaired glucose tolerance, beta-cell glucose sensitivity, first-phase insulin secretion, second-phase insulin secretion, C-peptide, hyperglycemic clamp, oral glucose tolerance test, insulin resistance, prediabetes, Mexican Americans
- MeSH terms
- Adult, Blood Glucose, Fasting, Female, Glucose Tolerance Test, Humans, Insulin Resistance, Male, Middle Aged, Glucose Intolerance, Area Under Curve, Insulin-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.